DE602005005522T2 - In-situ-erzeugung eines implantats für tiere - Google Patents

In-situ-erzeugung eines implantats für tiere Download PDF

Info

Publication number
DE602005005522T2
DE602005005522T2 DE602005005522T DE602005005522T DE602005005522T2 DE 602005005522 T2 DE602005005522 T2 DE 602005005522T2 DE 602005005522 T DE602005005522 T DE 602005005522T DE 602005005522 T DE602005005522 T DE 602005005522T DE 602005005522 T2 DE602005005522 T2 DE 602005005522T2
Authority
DE
Germany
Prior art keywords
composition according
biologically active
composition
solvent
thermoplastic polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005005522T
Other languages
German (de)
English (en)
Other versions
DE602005005522D1 (de
Inventor
Caroline Sautter
Ute Isele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE602005005522D1 publication Critical patent/DE602005005522D1/de
Application granted granted Critical
Publication of DE602005005522T2 publication Critical patent/DE602005005522T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE602005005522T 2004-12-14 2005-12-13 In-situ-erzeugung eines implantats für tiere Active DE602005005522T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04029498 2004-12-14
EP04029498 2004-12-14
PCT/EP2005/013377 WO2006063794A1 (en) 2004-12-14 2005-12-13 In-situ forming implant for animals

Publications (2)

Publication Number Publication Date
DE602005005522D1 DE602005005522D1 (de) 2008-04-30
DE602005005522T2 true DE602005005522T2 (de) 2009-04-16

Family

ID=34927750

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005005522T Active DE602005005522T2 (de) 2004-12-14 2005-12-13 In-situ-erzeugung eines implantats für tiere

Country Status (16)

Country Link
JP (1) JP5372378B2 (zh)
KR (1) KR101304160B1 (zh)
CN (1) CN101056617B (zh)
AR (1) AR052155A1 (zh)
AT (1) ATE389386T1 (zh)
AU (1) AU2005315823B2 (zh)
BR (1) BRPI0519022A2 (zh)
CA (1) CA2585779C (zh)
DE (1) DE602005005522T2 (zh)
ES (1) ES2301084T3 (zh)
MX (1) MX2007007099A (zh)
NZ (1) NZ554904A (zh)
RU (1) RU2394558C2 (zh)
TW (1) TWI369218B (zh)
WO (1) WO2006063794A1 (zh)
ZA (1) ZA200703506B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
CA2687979C (en) 2007-05-25 2017-07-04 Tolmar Therapeutics, Inc. Sustained delivery formulations of risperidone compounds
CN101159064B (zh) 2007-11-29 2010-09-01 腾讯科技（深圳）有限公司 画像生成系统以及按照图像生成画像的方法
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
JP6543431B2 (ja) * 2013-10-10 2019-07-10 ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 眼内薬物送達デバイスおよび付随する方法
PL3609470T3 (pl) 2017-04-13 2024-04-15 Ceva Santé Animale Implant do leczenia infekcji pasożytniczej
CN112336682B (zh) * 2020-09-28 2022-07-08 浙江大学 具有缓控释药物作用的可注射复合载体与组合物及制备方法
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
EP0959873B1 (en) * 1996-12-20 2006-03-01 ALZA Corporation Gel composition and methods
IL137982A0 (en) * 1998-03-19 2001-10-31 Merck & Co Inc Liquid polymeric compositions of controlled release of bioactive substances
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
JP4317606B2 (ja) * 1998-09-18 2009-08-19 サンスター株式会社 固体粒子形成用組成物
AU2003295409B2 (en) * 2002-11-06 2010-02-11 Durect Corporation Controlled release depot formulations
JP2007525429A (ja) * 2003-03-11 2007-09-06 キューエルティー ユーエスエー，インコーポレイテッド． 細胞スケジュール依存性抗癌剤のための処方

Also Published As

Publication number Publication date
WO2006063794A1 (en) 2006-06-22
RU2007126759A (ru) 2009-01-27
CA2585779C (en) 2014-01-28
DE602005005522D1 (de) 2008-04-30
MX2007007099A (es) 2007-06-22
AR052155A1 (es) 2007-03-07
BRPI0519022A2 (pt) 2008-12-23
TWI369218B (en) 2012-08-01
ZA200703506B (en) 2008-09-25
JP2008523131A (ja) 2008-07-03
ATE389386T1 (de) 2008-04-15
CN101056617A (zh) 2007-10-17
AU2005315823B2 (en) 2009-06-04
TW200635616A (en) 2006-10-16
CA2585779A1 (en) 2006-06-22
KR101304160B1 (ko) 2013-09-04
AU2005315823A1 (en) 2006-06-22
CN101056617B (zh) 2012-07-11
ES2301084T3 (es) 2008-06-16
JP5372378B2 (ja) 2013-12-18
KR20070092964A (ko) 2007-09-14
NZ554904A (en) 2009-11-27
RU2394558C2 (ru) 2010-07-20

Similar Documents

Publication Publication Date Title
DE602005005522T2 (de) In-situ-erzeugung eines implantats für tiere
DE60111068T3 (de) Polymere verabreichungsform von leuprolid mit verbesserter wirksamkeit
DE69634277T2 (de) Kontrolliertes zuführsystem mit einer flüssigkeit von hoher viskosität
DE69914787T2 (de) Flüssige zusammensetzungen mit kontrollierter freigabe mit niedrigem initialfreisetzungsstoss des wirkstoffs
DE69632569T2 (de) Formulierungen und verfahren für eine verlängerte lokalanästhesie
EP1484033B1 (en) Liquid polymeric compositions for controlled release of bioactive substances
DE60017956T2 (de) Biodegradierbare polymerzusammensetzung
DE60003803T2 (de) Trockene formbare arzneistoffformulierung
DE4117249C2 (de) Linsidomin zur Behandlung erektiler Dysfunktionen
ES2359973T3 (es) Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
DE69927963T2 (de) Gelierbare pharmazeutische zusammensetzungen
EP0537559B1 (en) Polymeric compositions useful as controlled release implants
DE3780862T2 (de) Implantate zur abgabe biologisch aktiver makromolekuele.
DE69932201T2 (de) Emulsionen für in-situ Arzneistoffabgabesysteme
EP0311065A1 (de) Implantierbares, biologisch abbaubares Wirkstofffreigabesystem
DE10297018T5 (de) Depotmikrokügelchen für die Injektion von Huperzin-A-Verbindungen
EP1827377B1 (en) In-situ forming implant for animals
JP2005538052A (ja) 注射製剤
PT1484033E (pt) Composições poliméricas líquidas para libertação controlada de substâncias bioactivas
DE1467861C (de) Verwendung von Organopolysiloxan elastomeren als A^zneimitteltrager in fester Form
WO2015158823A1 (de) Veterinärpharmazeutische zusammensetzung und deren verwendung
WO2011120608A1 (de) Implantatskanüle mit implantat und verfahren zum befestigen von implantaten in einer injektionskanüle
DE10314082A1 (de) Biodegradierbares injizierbares Implantat
DE1467861A1 (de) Verwendung von Organopolysiloxanelastomeren als Arzneimitteltraeger in fester Form mit kontrollierbarer Wirkstofffreigabe
DE1467861B (de) Verwendung von Organopolysiloxanelastomeren als Arzneimittelträger in fester Form

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC